^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GP2

    i
    Associations
    News

    Trials

    Company:
    Generex, Greenwich LifeSci
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Phase 3 Study to Evaluate the Efficacy and Safety of HER2/neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/neu Positive Subjects (FLAMINGO-01) (NCT05232916)
    Phase 3
    Greenwich LifeSciences, Inc.
    Recruiting
    Last update posted :
    02/21/2025
    Initiation :
    08/11/2022
    Primary completion :
    12/01/2026
    Completion :
    12/01/2026
    HER-2 • HLA-A
    |
    HLA-A*02 positive
    |
    Herceptin (trastuzumab) • GLSI-100 • GP2